Orion Infusion Limited (DSE:ORIONINFU)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
365.00
-14.60 (-3.85%)
At close: Dec 4, 2025
20.50%
Market Cap7.43B
Revenue (ttm)631.54M
Net Income (ttm)35.63M
Shares Out20.36M
EPS (ttm)1.75
PE Ratio208.56
Forward PEn/a
Dividend2.00 (0.55%)
Ex-Dividend DateDec 2, 2025
Volume296,382
Average Volume318,226
Open372.00
Previous Close379.60
Day's Range349.00 - 374.40
52-Week Range265.40 - 587.50
Beta-2.41
RSI40.61
Earnings DateNov 9, 2025

About Orion Infusion

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. It also provides sterile and nonpyrogenic solution, such as Dextrolac, Dianak, Hartman, Manisol, Plasmasol, and Proliv; hypertonic solution, including Dextrosal, Electrodex-10, Fructose – 10, Orlev, Ortac; Dextropac, an isoto... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1983
Employees 563
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ORIONINFU
Full Company Profile

Financial Performance

In 2025, Orion Infusion's revenue was 664.92 million, a decrease of -19.64% compared to the previous year's 827.42 million. Earnings were 35.02 million, a decrease of -17.27%.

Financial Statements

News

There is no news available yet.